BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Li SH. The Clinical Outcomes of Locally Advanced Cervical Esophageal Squamous Cell Carcinoma Patients Receiving Curative Concurrent Chemoradiotherapy: A Population-Based Propensity Score-Matched Analysis. Cancers (Basel) 2019;11:E451. [PMID: 30934987 DOI: 10.3390/cancers11040451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen P, Zhao X, Zhou F, Song X, Hu S, Jin Y, Wang X, Han X, Fan Z, Wang R, Li B, Han W, Wang P, Li J, Wan L, Zhang L, Bao Q, Chang F, Qin Y, Chang Z, Ku J, Yang H, Yuan L, Ren J, Li X, Wang L. Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes. Cancer Biol Med 2020;17:219-26. [PMID: 32296589 DOI: 10.20892/j.issn.2095-3941.2019.0268] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Lu Y, Guo L, Ding G. PD1+ tumor associated macrophages predict poor prognosis of locally advanced esophageal squamous cell carcinoma. Future Oncol 2019;15:4019-30. [PMID: 31612729 DOI: 10.2217/fon-2019-0519] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhi X, Jiang K, Shen Y, Su X, Wang K, Ma Y, Zhou L. Peripheral blood cell count ratios are predictive biomarkers of clinical response and prognosis for non-surgical esophageal squamous cell carcinoma patients treated with radiotherapy. J Clin Lab Anal 2020;34:e23468. [PMID: 32681567 DOI: 10.1002/jcla.23468] [Cited by in F6Publishing: 1] [Reference Citation Analysis]